{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:20Z","timestamp":1793377940144,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109048","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:19:07Z","timestamp":1784906347000},"page":"109048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-4942","authenticated-orcid":false,"given":"Laura","family":"Pini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Beghe\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-0765","authenticated-orcid":false,"given":"Matteo","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1134-059X","authenticated-orcid":false,"given":"Marco","family":"Caminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-4704","authenticated-orcid":false,"given":"Giovanna Elisiana","family":"Carpagnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-2722","authenticated-orcid":false,"given":"Manuela","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5319","authenticated-orcid":false,"given":"Laura","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-992X","authenticated-orcid":false,"given":"Andrea","family":"Matucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-8253","authenticated-orcid":false,"given":"Pierachille","family":"Santus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-6573","authenticated-orcid":false,"given":"Nicola","family":"Scichilone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-3216","authenticated-orcid":false,"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Spanevello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-9970","authenticated-orcid":false,"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-2557","authenticated-orcid":false,"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109048_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109048_bib2","series-title":"GINA Main Report","year":"2025"},{"key":"10.1016\/j.rmed.2026.109048_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100606","article-title":"Severe asthma: one disease and multiple definitions","volume":"14","author":"Bagnasco","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.rmed.2026.109048_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaip.2020.10.035","article-title":"The relationship of asthma biologics to remission for asthma","volume":"9","author":"Menzies-Gow","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0181-2024","article-title":"Pro: clinical remission in asthma \u2013 implications for asthma management","volume":"34","author":"Principe","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.109048_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2024.09.021","article-title":"The role of biologics in inducing remission in asthma","volume":"134","author":"Busse","year":"2025","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaip.2024.01.044","article-title":"Targeting asthma remission as the next therapeutic step toward improving disease control","volume":"12","author":"Busse","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2026.109048_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2026.109048_bib11","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","article-title":"Severe asthma network Italy definition of clinical remission in severe asthma: a Delphi consensus","volume":"11","author":"Canonica","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-022-01714-5","article-title":"Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma","volume":"28","author":"Kachroo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109048_bib14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma findings from the NORDSTAR cohort","volume":"13","author":"Von B\u00fclow","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874306401408010093","article-title":"Inhaled corticosteroids and secondary adrenal insufficiency","volume":"8","author":"Sannarangappa","year":"2014","journal-title":"Open Respir. Med. J."},{"key":"10.1016\/j.rmed.2026.109048_bib16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jaip.2023.03.009","article-title":"Severe asthma standard-of-care background medication reduction with benralizumab: ANDHI in practice substudy","volume":"11","author":"Louis","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2026.109048_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1081-1206(10)62170-9","article-title":"Omalizumab is effective in the long-term control of severe allergic asthma","volume":"91","author":"Lanier","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2222.2004.1916.x","article-title":"Efficacy and safety of a recombinant anti\u2010immunoglobulin E antibody (omalizumab) in severe allergic asthma","volume":"34","author":"Holgate","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2026.109048_bib20","doi-asserted-by":"crossref","first-page":"A4779","DOI":"10.1016\/j.chest.2024.06.2861","article-title":"Dupilumab improves asthma control and reduces fractional exhaled nitric oxide and exacerbations with inhaled corticosteroid withdrawal: a phase 2 study","volume":"166","author":"Wechsler","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.109048_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.109048_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2026.04.010","article-title":"Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: a post hoc analysis","author":"Wechsler","year":"2026","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib23","doi-asserted-by":"crossref","first-page":"AB26","DOI":"10.1016\/j.jaci.2015.12.084","article-title":"Reduction in corticosteroid use among patients receiving omalizumab in real world settings: a systematic literature review of non-randomized studies","volume":"137","author":"Panettieri","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.anai.2021.11.005","article-title":"A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumab","volume":"128","author":"Corren","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2024-4-2","article-title":"Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series","volume":"13","author":"Lombardi","year":"2024","journal-title":"Drugs Context"},{"key":"10.1016\/j.rmed.2026.109048_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101899","article-title":"Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life","volume":"61","author":"Sposato","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2026.109048_bib27","doi-asserted-by":"crossref","DOI":"10.4081\/mrm.2021.785","article-title":"Real world effectiveness of benralizumab on respiratory function and asthma control","volume":"16","author":"Menzella","year":"2021","journal-title":"Multidis. Res. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib28","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.3390\/jcm13103013","article-title":"Unlocking the long-term effectiveness of benralizumab in severe eosinophilic asthma: a three-year real-life study","volume":"13","author":"Pini","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1183\/23120541.00383-2023","article-title":"Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction \u2013 PROMISE","volume":"9","author":"Schleich","year":"2023","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.rmed.2026.109048_bib30","doi-asserted-by":"crossref","first-page":"JC43","DOI":"10.7326\/J24-0014","article-title":"In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control","volume":"177","author":"Stanbrook","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2147\/JAA.S472490","article-title":"Benralizumab: effectiveness in patients with uncontrolled severe eosinophilic asthma at 6 and 12 months at a third-level care hospital. Capacity for ICS-LABA therapy reduction","volume":"17","author":"Gonz\u00e1lez-Tuyub","year":"2024","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.rmed.2026.109048_bib32","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jaip.2025.04.032","article-title":"Impact of biologics initiation on oral corticosteroid use in the international severe asthma registry and the optimum patient care research database: a pooled analysis of real-world data","volume":"13","author":"Chen","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2026.109048_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.arbres.2025.08.001","article-title":"Inhaled corticosteroid reduction effects on asthma outcomes after three years of benralizumab treatment in severe asthma patients","volume":"62","author":"Arteaga","year":"2026","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.rmed.2026.109048_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108198","article-title":"ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up","volume":"245","author":"Pini","year":"2025","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib35","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jaip.2025.05.046","article-title":"Ushering in the era of corticosteroid stewardship: what is the impact of biologics on this asthma burden?","volume":"13","author":"Szefler","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2022.10.040","article-title":"Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK database study","volume":"11","author":"Pavord","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib37","article-title":"ARRIVAL: a phase 3b study to assess potential for tezepelumab to reduce maintenance inhaled therapy and induce remission in patients with severe asthma. Airway pharmacology and treatment","author":"Israel","year":"2024","journal-title":"Eur. Respir. Soc."},{"key":"10.1016\/j.rmed.2026.109048_bib38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jaip.2025.05.031","article-title":"How to adjust asthma management once asthma is controlled on long-term biologic therapy","volume":"13","author":"Wechsler","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2026.109048_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2026.100577","article-title":"Expert opinion and evidence-based review on maintenance therapy step-down in patients with severe asthma controlled with biologics","volume":"8","author":"Plaza","year":"2026","journal-title":"Open Respir. Arch."},{"key":"10.1016\/j.rmed.2026.109048_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2009.00010","article-title":"The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey","volume":"18","author":"Thomas","year":"2009","journal-title":"Prim. Care Respir. J."},{"key":"10.1016\/j.rmed.2026.109048_bib41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/cells13161355","article-title":"Breath and sputum analyses in asthmatic patients: an overview","volume":"13","author":"Soccio","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.rmed.2026.109048_bib42","first-page":"A210.2","article-title":"P173 Clinical utility of sputum cell count in severe asthma","author":"Khan","year":"2024"},{"key":"10.1016\/j.rmed.2026.109048_bib43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaip.2025.01.010","article-title":"Mucus plug score predicts clinical and pulmonary function response to biologic therapy in patients with severe asthma","volume":"13","author":"G\u00f6tschke","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109048_bib44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1378\/chest.11-0618","article-title":"Point: is measuring sputum eosinophils useful in the management of severe asthma?","volume":"139","author":"Hargreave","year":"2011","journal-title":"Yes. Chest"},{"key":"10.1016\/j.rmed.2026.109048_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2026.109048_bib46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1164\/rccm.202406-1244ED","article-title":"Breaking up mucus plugs in asthma","volume":"210","author":"Busse","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109048_bib47","article-title":"Clinical predictors and phenotypic associations of mucus plugging in moderate to severe asthma","volume":"vol 4318","author":"Chan","year":"2022"},{"key":"10.1016\/j.rmed.2026.109048_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.969243","article-title":"Critical evaluation of asthma biomarkers in clinical practice","volume":"9","author":"Guida","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2026.109048_bib49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1164\/rccm.202412-2438OC","article-title":"Clinical remission by a comprehensive severe asthma management strategy guided by airway inflammometry and bioimaging","volume":"211","author":"Nolasco","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109048_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.839011","article-title":"Omalizumab and IgE in the control of severe allergic asthma","volume":"13","author":"Gon","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2026.109048_bib51","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Toward clinically applicable biomarkers for asthma: an EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109048_bib52","first-page":"120","article-title":"Relationship between serum total IgE and disease severity in patients with allergic asthma in Spain","volume":"25","author":"Davila","year":"2015","journal-title":"J Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.109048_bib53","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.3390\/jcm14134749","article-title":"Biologic therapy in severe asthma: a phenotype-driven and targeted approach","volume":"14","author":"D'Amato","year":"2025","journal-title":"J. Clin. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:37:08Z","timestamp":1793374628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S0954611126004166"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109048","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109048"}}